| Autor: |
Yao P; Joint Surgery Department, The Second People's Hospital of Zhangye City, Zhangye, China., Lu Y; Department of Spine Surgery, The Third Affiliated Hospital, 144991Sun Yat-sen University, Guangzhou, China., Cai Z; Lanzhou University Second Clinical Medical College, Lanzhou, China., Yu T; Lanzhou University Second Clinical Medical College, Lanzhou, China., Kang Y; Lanzhou University Second Clinical Medical College, Lanzhou, China., Zhang Y; Joint Surgery Department, The Second People's Hospital of Zhangye City, Zhangye, China., Wang X; Joint Surgery Department, The Second People's Hospital of Zhangye City, Zhangye, China. |
| Abstrakt: |
Currently, although the improvement of surgical techniques and the development of chemotherapy drugs have brought a certain degree of development to the treatment of osteosarcoma, the treatment of osteosarcoma has many shortcomings, and its treatment is limited. MiRNAs and exosomes can be used as diagnostic tools, and they play an important role in the occurrence and chemotherapy resistance of osteosarcoma. Therefore, providing a new method for the treatment of osteosarcoma is the key to solving this problem. To systematically summarize the research status of exoskeleton drug-loaded miRNA in osteosarcoma, we identified and evaluated 208 studies and found that exosome-carrying miRNA can be used as an index for the diagnosis and prognosis of osteosarcoma and share a certain relationship with chemosensitivity. In addition, exosomes can also be used as a carrier of genetic drugs able to regulate the progression of osteosarcoma. Based on the above findings, we propose suggestions for the future development of this field, aiming to bring new ideas for the early diagnosis and treatment of osteosarcoma. |
